Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| U1111-1285-1486 | Other Identifier | World Health Organization (WHO) |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to understand the personal flow along the weight loss management journey. A range of variables will be addressed in a survey to explore the weight loss journey, barriers and management. Topics include weight loss strategies and challenges, HCP involvement, and perceptions towards weight loss medications.
Potential participants will be recruited using various online panels. Study participants will be recruited to participate in 2 types of qualitative research.
Phase I: Online bulletin boards (OBB) Phase II: Virtual focus groups (real-time)
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Phase I | Online bulletin boards (OBB) |
| |
| Phase II | Virtual focus groups (real-time) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| No treatment given | Other | No treatment given |
|
| Measure | Description | Time Frame |
|---|---|---|
| Description of perceptions, behaviours and awareness related to obesity and obesity management among people living with obesity. | 120-minute OBB discussion with numeric and open-ended response (Phase 1) | 5 days (Phase 1) |
| Description of perceptions, behaviours and awareness related to obesity and obesity management among people living with obesity. | 90-minute focus group with open-ended response (Phase 2) | 1 day (Phase 2) |
| Assessment of triggers for people with obesity to request medical therapy and expectations for both therapy available and their weight loss journey. | 120-minute OBB discussion with numeric and open-ended response (Phase 1) | 5 days (Phase 1) |
| Assessment of triggers for people with obesity to request medical therapy and expectations for both therapy available and their weight loss journey. | 90-minute focus group with open-ended response (Phase 2) | 1 day (Phase 2) |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Study participants will be recruited to participate in 2 types of qualitative research. Online Bulletin Boards and Virtual Focus Groups
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Clinical Transparency (dept. 2834) | Novo Nordisk A/S | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Novo Nordisk Investigational Site | Bengaluru | India |
"According to the Novo Nordisk disclosure commitment on novonordisk-trials.com"
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009765 | Obesity |
| ID | Term |
|---|---|
| D050177 | Overweight |
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| D001835 |
| Body Weight |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |